electroCore
NJ - RockawayBiotechnology
Focus: Neuromodulation
electroCore is a life sciences company focused on Neuromodulation.
Profile data last refreshed 2d ago
Funding Stage
SERIES B
Total Funding
$55M
Open Jobs
0
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
31 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
non-invasive Vagus Nerve Stimulator
Ischemic StrokeClinical Trials (1)
NCT04050501Non-invasive Vagus Nerve Stimulation in Acute Ischemic Stroke
N/AHelp build intelligence for electroCore
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.